Jay R. Venkatesan's most recent trade in Elicio Therapeutics Inc. was a trade of 7,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | 26 Nov 2024 | 50,000 | 179,581 | - | 0.0 | 500 | Common Stock | |
Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | 26 Nov 2024 | 50,000 | 0 | - | - | Warrant to Purchase Common Stock | ||
Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants |